Literature DB >> 8092926

Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo.

A M Jenner1, J A Timbrell.   

Abstract

Hydrazine hepatotoxicity in vivo, as manifested by triglyceride accumulation, depletion of ATP and reduced glutathione (GSH) was shown to be dose related. The effect of pretreatment of rats with various inhibitors and inducers of cytochrome P450 on these dose-response relationships was investigated. Pretreatment with the inhibitor piperonyl butoxide increased triglyceride accumulation whereas pretreatment with the inducers phenobarbital and beta-naphthoflavone (BNF) resulted in reduced triglyceride accumulation. Pretreatment with the inducers acetone and isoniazid also enhanced triglyceride accumulation. Only phenobarbital pretreatment also significantly reduced GSH and ATP depletion. A linear correlation was found between hepatic glutathione and ATP levels in non-pretreated animals given various doses of hydrazine. However, exponential relationships were found between hepatic triglycerides and both hepatic ATP and glutathione. The results suggest that i) the hepatotoxicity of hydrazine can be modulated by inducing or inhibiting particular isoenzymes of cytochrome P450, ii) ATP and GSH depletion may not be directly involved in the development of fatty liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092926     DOI: 10.1007/s002040050081

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  29 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

Review 2.  Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity.

Authors:  C S Yang; J F Brady; J Y Hong
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

3.  On the question of the carcinogenic action of hydrazine--evaluation on the basis of new experimental results.

Authors:  D Steinhoff; U Mohr; W M Schmidt
Journal:  Exp Pathol       Date:  1990

4.  Identification of novel hydrazine metabolites by 15N-NMR.

Authors:  N E Preece; J K Nicholson; J A Timbrell
Journal:  Biochem Pharmacol       Date:  1991-05-01       Impact factor: 5.858

5.  Spin trapping of a free radical intermediate formed during microsomal metabolism of hydrazine.

Authors:  A Noda; H Noda; K Ohno; T Sendo; A Misaka; Y Kanazawa; R Isobe; M Hirata
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

6.  Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies.

Authors:  I Johansson; G Ekström; B Scholte; D Puzycki; H Jörnvall; M Ingelman-Sundberg
Journal:  Biochemistry       Date:  1988-03-22       Impact factor: 3.162

7.  Potentiation of the hepatotoxicity of N-nitrosodimethylamine by fasting, diabetes, acetone, and isopropanol.

Authors:  N A Lorr; K W Miller; H R Chung; C S Yang
Journal:  Toxicol Appl Pharmacol       Date:  1984-05       Impact factor: 4.219

8.  Identification and quantitation of hydrazine in the urine of patients treated with hydralazine.

Authors:  J A Timbrell; S J Harland
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

9.  Plasma hydrazine concentrations in man after isoniazid and hydralazine administration.

Authors:  I A Blair; R Mansilla Tinoco; M J Brodie; R A Clare; C T Dollery; J A Timbrell; I A Beever
Journal:  Hum Toxicol       Date:  1985-03

10.  Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a.

Authors:  D R Koop
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

View more
  5 in total

Review 1.  Hepatotoxic effects of therapies for tuberculosis.

Authors:  Bahaa E Senousy; Sanaa I Belal; Peter V Draganov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-31       Impact factor: 46.802

2.  The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.

Authors:  John Mach; Aniko Huizer-Pajkos; Sarah J Mitchell; Catriona McKenzie; Leo Phillips; Alice Kane; Brett Jones; Rafael de Cabo; Victoria Cogger; David G Le Couteur; Sarah N Hilmer
Journal:  Fundam Clin Pharmacol       Date:  2015-11-09       Impact factor: 2.748

Review 3.  Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer.

Authors:  Can Cheng; Songming Zhuo; Bo Zhang; Xu Zhao; Ying Liu; Chaoliang Liao; Jing Quan; Zhenzhen Li; Ann M Bode; Ya Cao; Xiangjian Luo
Journal:  Int J Biol Sci       Date:  2019-06-04       Impact factor: 6.580

4.  Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches.

Authors:  Sudin Bhattacharya; Lisl K M Shoda; Qiang Zhang; Courtney G Woods; Brett A Howell; Scott Q Siler; Jeffrey L Woodhead; Yuching Yang; Patrick McMullen; Paul B Watkins; Melvin E Andersen
Journal:  Front Physiol       Date:  2012-12-14       Impact factor: 4.566

5.  Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.

Authors:  Yong Lian; Jing Zhao; Peiyu Xu; Yimei Wang; Jun Zhao; Li Jia; Ze Fu; Li Jing; Gang Liu; Shuangqing Peng
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.